Avai Bio (AVAI) Consolidated Net Income (2018 - 2024)
Avai Bio's Consolidated Net Income history spans 6 years, with the latest figure at -$4.8 million for Q1 2024.
- For Q1 2024, Consolidated Net Income fell 738.05% year-over-year to -$4.8 million; the TTM value through Mar 2024 reached -$7.4 million, down 2031.53%, while the annual FY2025 figure was -$1.1 million, 61.63% up from the prior year.
- Consolidated Net Income for Q1 2024 was -$4.8 million at Avai Bio, down from -$1.8 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $417163.0 in Q4 2020 and bottomed at -$4.8 million in Q1 2024.
- The 4-year median for Consolidated Net Income is $21606.5 (2020), against an average of -$602864.7.
- The largest annual shift saw Consolidated Net Income skyrocketed 4203.92% in 2020 before it crashed 1752.06% in 2023.
- A 4-year view of Consolidated Net Income shows it stood at $417163.0 in 2020, then plummeted by 73.52% to $110471.0 in 2022, then plummeted by 1752.06% to -$1.8 million in 2023, then crashed by 163.09% to -$4.8 million in 2024.
- Per Business Quant, the three most recent readings for AVAI's Consolidated Net Income are -$4.8 million (Q1 2024), -$1.8 million (Q4 2023), and -$399621.0 (Q3 2023).